Change and impact of left ventricular global longitudinal strain during transcatheter aortic valve implantation.
Aortic stenosis
Ejection fraction
Left ventricular global longitudinal strain
Longitudinal strain
Transcatheter aortic valve implantation
Journal
World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806
Informations de publication
Date de publication:
26 Feb 2022
26 Feb 2022
Historique:
received:
24
11
2021
revised:
04
01
2022
accepted:
17
01
2022
entrez:
23
3
2022
pubmed:
24
3
2022
medline:
24
3
2022
Statut:
ppublish
Résumé
Although transcatheter aortic valve implantation (TAVI) is a safe and effective treatment for aortic stenosis, it still carries some risks, such as valve leaks, stroke, and even death. The left ventricular global longitudinal strain (LVGLS) measurement may be useful for the prediction of adverse events during this operation. To explore the change of LVGLS during TAVI procedure and the relationship between LVGLS and perioperative adverse events. In this study, 61 patients who had undergone percutaneous transfemoral TAVI were evaluated by transthoracic echocardiography. Before surgery, data on left ventricular ejection fraction (LVEF) and LVGLS were collected separately following balloon expansion and stent implantation. Difference in values of LVGLS and LVEF during preoperative balloon expansion (pre-ex), preoperative stent implantation (pre-im) and balloon expansion-stent implantation (ex-im) were also examined. Adverse events were defined as perioperative death, cardiac rupture, heart arrest, moderate or severe perivalvular leakage, significant mitral regurgitation during TAVI, perioperative moderate or severe mitral regurgitation, perioperative left ventricular outflow tract obstruction, reoperation, and acute heart failure. The occurrence of perioperative adverse events was associated with differences in pre-ex LVGLS, but not with difference in pre-ex LVEF. There were significant differences between pre-LVGLS and ex-LVGLS, and between pre-LVGLS and im-LVGLS ( Greater attention should be paid to the patients who plan to undergo TAVI with normal LVEF but poor LVGLS.
Sections du résumé
BACKGROUND
BACKGROUND
Although transcatheter aortic valve implantation (TAVI) is a safe and effective treatment for aortic stenosis, it still carries some risks, such as valve leaks, stroke, and even death. The left ventricular global longitudinal strain (LVGLS) measurement may be useful for the prediction of adverse events during this operation.
AIM
OBJECTIVE
To explore the change of LVGLS during TAVI procedure and the relationship between LVGLS and perioperative adverse events.
METHODS
METHODS
In this study, 61 patients who had undergone percutaneous transfemoral TAVI were evaluated by transthoracic echocardiography. Before surgery, data on left ventricular ejection fraction (LVEF) and LVGLS were collected separately following balloon expansion and stent implantation. Difference in values of LVGLS and LVEF during preoperative balloon expansion (pre-ex), preoperative stent implantation (pre-im) and balloon expansion-stent implantation (ex-im) were also examined. Adverse events were defined as perioperative death, cardiac rupture, heart arrest, moderate or severe perivalvular leakage, significant mitral regurgitation during TAVI, perioperative moderate or severe mitral regurgitation, perioperative left ventricular outflow tract obstruction, reoperation, and acute heart failure.
RESULTS
RESULTS
The occurrence of perioperative adverse events was associated with differences in pre-ex LVGLS, but not with difference in pre-ex LVEF. There were significant differences between pre-LVGLS and ex-LVGLS, and between pre-LVGLS and im-LVGLS (
CONCLUSION
CONCLUSIONS
Greater attention should be paid to the patients who plan to undergo TAVI with normal LVEF but poor LVGLS.
Identifiants
pubmed: 35317147
doi: 10.12998/wjcc.v10.i6.1806
pmc: PMC8891760
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1806-1814Informations de copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Références
Circ Cardiovasc Imaging. 2018 Aug;11(8):e007131
pubmed: 30354492
J Thorac Cardiovasc Surg. 2014 Feb;147(2):568-75
pubmed: 24263007
J Am Coll Cardiol. 2012 Nov 6;60(19):1854-63
pubmed: 23062541
Int J Cardiovasc Imaging. 2016 Apr;32(4):593-601
pubmed: 26608801
Eur Heart J. 2018 Feb 21;39(8):699-709
pubmed: 29020257
J Am Soc Echocardiogr. 2019 Apr;32(4):431-475
pubmed: 30797660
Int J Cardiol. 2016 Oct 15;221:218-26
pubmed: 27404678
Cardiovasc Ultrasound. 2012 Mar 26;10:15
pubmed: 22448716
Am Heart J. 2010 May;159(5):926-32
pubmed: 20435207
Int J Cardiovasc Imaging. 2016 Feb;32(2):247-259
pubmed: 26323357
N Engl J Med. 2010 Oct 21;363(17):1597-607
pubmed: 20961243
Lancet. 2016 May 28;387(10034):2218-25
pubmed: 27053442
Circulation. 2009 Aug 18;120(7):577-84
pubmed: 19652094
JACC Cardiovasc Imaging. 2019 Jan;12(1):163-171
pubmed: 30621988
Am J Cardiovasc Dis. 2011;1(3):264-73
pubmed: 22254204
JACC Cardiovasc Imaging. 2019 Feb;12(2):283-296
pubmed: 30732723
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Cardiol J. 2018;25(4):487-494
pubmed: 29924376
Heart. 2020 Jul;106(13):962-969
pubmed: 32179586
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811
Am J Cardiol. 2019 Mar 15;123(6):956-960
pubmed: 30594290